Scholarlink

Purpose <p>Response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer remains heterogeneous. This exploratory study evaluated whether radiomics features extracted from the clinical target volume (CTV) on pretreatment non-contrast radiotherapy planning CT could provide additional information for pretreatment prediction of poor treatment response.</p> Methods <p>This retrospective single-center study included 60&#xa0;patients with rectal cancer treated with nCRT between 2008 and 2024, including 50 good responders and 10 poor responders. A&#xa0;total of 1148 radiomics features were extracted from the original pretreatment treatment-planning CTV and combined with clinical variables, including age, sex, cT stage, cN stage, log-transformed carcinoembryonic antigen, and tumor-to-anal verge distance. Models were internally evaluated using repeated nested cross-validation with fold-wise ComBat harmonization. Performance was assessed from pooled repeated out-of-fold predictions, including discrimination, apparent calibration, exploratory threshold-based operating characteristics, and decision curve analysis.</p> Results <p>The best-performing combined clinical–radiomics model was Extra Trees, with an area under the receiver operating characteristic curve of 0.754 (95% confidence interval [CI], 0.713–0.789), compared with 0.507 for the clinical-only model. At a&#xa0;post hoc sensitivity-prioritized operating threshold, the combined Extra Trees model achieved sensitivity of 0.94 (95% CI, 0.89–0.98), specificity of 0.47 (95% CI, 0.42–0.51), and negative predictive value of 0.98 in pooled repeated out-of-fold analysis. Decision curve analysis suggested potential net benefit across low-to-moderate threshold probabilities in internal analysis.</p> Conclusion <p>Clinical target volume-based radiomics from routine pretreatment non-contrast planning CT may provide exploratory information for prediction of poor response to nCRT in rectal cancer. Because treatment-planning CTVs are routinely generated before radiotherapy, this workflow may be practical for radiotherapy-based research. The findings are hypothesis generating and require external validation before clinical use.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical target volume radiomics from planning CT for pretreatment response prediction  in rectal cancer undergoing chemoradiotherapy

  • 期刊论文

  • 发表日期：

    2026年7月17日

查看全文
  • Yen-Cho Huang,
  • Shih-Ming Huang,
  • Jih-Hsiang Yeh,
  • Shu-Ju Tu

摘要

Purpose

Response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer remains heterogeneous. This exploratory study evaluated whether radiomics features extracted from the clinical target volume (CTV) on pretreatment non-contrast radiotherapy planning CT could provide additional information for pretreatment prediction of poor treatment response.

Methods

This retrospective single-center study included 60 patients with rectal cancer treated with nCRT between 2008 and 2024, including 50 good responders and 10 poor responders. A total of 1148 radiomics features were extracted from the original pretreatment treatment-planning CTV and combined with clinical variables, including age, sex, cT stage, cN stage, log-transformed carcinoembryonic antigen, and tumor-to-anal verge distance. Models were internally evaluated using repeated nested cross-validation with fold-wise ComBat harmonization. Performance was assessed from pooled repeated out-of-fold predictions, including discrimination, apparent calibration, exploratory threshold-based operating characteristics, and decision curve analysis.

Results

The best-performing combined clinical–radiomics model was Extra Trees, with an area under the receiver operating characteristic curve of 0.754 (95% confidence interval [CI], 0.713–0.789), compared with 0.507 for the clinical-only model. At a post hoc sensitivity-prioritized operating threshold, the combined Extra Trees model achieved sensitivity of 0.94 (95% CI, 0.89–0.98), specificity of 0.47 (95% CI, 0.42–0.51), and negative predictive value of 0.98 in pooled repeated out-of-fold analysis. Decision curve analysis suggested potential net benefit across low-to-moderate threshold probabilities in internal analysis.

Conclusion

Clinical target volume-based radiomics from routine pretreatment non-contrast planning CT may provide exploratory information for prediction of poor response to nCRT in rectal cancer. Because treatment-planning CTVs are routinely generated before radiotherapy, this workflow may be practical for radiotherapy-based research. The findings are hypothesis generating and require external validation before clinical use.